Lisa – Interview 17
Callum was 2lb 12oz at birth and at the age of four years was small compared to his peers. Since being on growth hormones Callum has now caught up and is nearly the same size as his peers. He continues to be in the trial and enjoys taking part.
Callum was three and a half years old when he started a clinical trial to test the dosage for growth hormones among children under the age of five years. Lisa, his mother, was introduced to the clinical trial by Callum’s paediatrician at their local hospital. Lisa had been told that her son would only reach 4;1 without treatment. She says that as a la this would be unfair on him so decided to enrol him on the trial. However, the decision was not immediate. Lisa talked to the team running the trial, Callum’s paediatrician, her family and of course Callum who was very keen to take part; Mummy I want to be like other children She explained to her son that it would involve daily injections. However, Callum’s Granddad has diabetes and has daily injections so Callum was familiar with injections; So Grandad has injections so I;ll have injections to make me grow Before being accepted on the trial Callum underwent a series of tests to make sure he met the criteria for inclusion into the trial. Callum would have received growth hormones as part of his standard care, being part of the trial meant he would have to have extra blood tests and scans Lisa couldn’t remember if it was a randomised trial, although she knows there were different groups as they told her Callum was on the highest dose. Callum has been in the trial for three years and recently has been invited to continue for another three years, which the family have agreed to. This means that Callum will continue to have blood tests every three months.
A key factor in making the decision to enrol Callum involved her own childhood experience of being bullied because of her size and she did not want that for her child.
Callum feels good that he is helping other people like him in the future. Callum also knows that he can withdraw from the trial at any time and this wouldn’t interfere with his normal care and treatment. Lisa felt it important that Callum was very much part of the decision to take part in the trial and coming off the trial. Lisa hasn’t yet received any feedback from the trial in terms of the overall progress although she does know Callum’s progress. He is doing really well and is so much more confident at school too. All travel expenses are paid. He has rarely missed any school time so it hasn’t been too demanding in terms of their time and energy.
Lisa understands the importance of clinical trials however, the primary reason taking part in the trial, initially, was for Callum’s personal benefit. However, Lisa feels that it is important to be informed of all the potential risks and side effects I think you need to go into things with both eyes ope.
Having her own experience and her family health background (diabetes) helped her to understand some of the medical terms used in the information pack they received prior to the study. However, she said that some parents may find it all a bit daunting, the medical terms, names of tests etc, so it is important that these are clearly explaine. Thus, Lisa felt that to improve the experience, the information parents receive about the study could be easier and clearer. Importantly, Lisa advices other parents who may be considering enrolling their child onto a clinical trial, to always listen to your child and speak to other people first before making a decision. Lisa also would like to know the overall results of the study when it is completed. Overall Lisa and Callum’s experiences of taking part in a clinical trial have been positive one, and they both would certainly consider taking part in another clinical trial in the future.